SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-05-002273
Filing Date
2005-04-27
Accepted
2005-04-27 16:38:05
Documents
4
Period of Report
2005-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. FORM 8-K b54818tte8vk.htm 8-K 36688
2 EX-2.1 AGREEMENT & PLAN OF MERGER DATED AS OF APRIL 21, 2005 b54818ttexv2w1.htm EX-2.1 328897
3 EX-99.1 EXCLUSIVE LICENSE AGREEMENT b54818ttexv99w1.txt EX-99.1 136902
4 EX-99.2 LETTER AGREEMENT DATED AS OF APRIL 21, 2005 b54818ttexv99w2.htm EX-99.2 5424
  Complete submission text file 0000950135-05-002273.txt   509546
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21481 | Film No.: 05776839
SIC: 2836 Biological Products, (No Diagnostic Substances)